314 filings
Page 6 of 16
8-K
okrx9xdz8ifyv2zav
17 Dec 20
Regulation FD Disclosure
8:11am
8-K
sf5rhscfq6io7xyb i6
1 Dec 20
Histogen Announces Preliminary Week 18 HST-001 Study Results for the Treatment of Androgenic Alopecia in Men
8:05am
D
3rwkv8usff9gdo0
18 Nov 20
$189.21K in options / securities to be acquired, sold $189.21K, 7 investors
4:41pm
8-K
vu1zay
16 Nov 20
Histogen Announces Closing of $4.5 Million Registered Direct Offering
4:10pm
424B5
ehes95 embi99y
12 Nov 20
Prospectus supplement for primary offering
5:14pm
8-K
3kp9tt
12 Nov 20
Histogen Announces $4.5 Million Registered Direct Offering
8:20am
8-K
wiyoc n6j3c1nd05g
10 Nov 20
Histogen Reports Third Quarter 2020 Earnings and Provides Business Update
4:15pm
8-K
63wwnrqz qb3zk0
27 Oct 20
Histogen and Amerimmune Enter into a Collaborative Development and Commercialization Agreement for Emricasan in the Treatment of COVID-19
8:05am
8-K
cjvd9jrsz g66
29 Sep 20
Histogen Announces Update for its HST-002 Dermal Filler Program
8:15am
8-K
d8f wd43qk9blz4sdi
27 Aug 20
Other Events
5:22pm
424B5
lg3 1huzbehf01vld4
27 Aug 20
Prospectus supplement for primary offering
5:20pm
EFFECT
hrb9l
27 Aug 20
Notice of effectiveness
12:15am
CORRESP
5zwgj3 5389
24 Aug 20
Correspondence with SEC
12:00am
UPLOAD
t1ac i6vpcdmr0cink7
24 Aug 20
Letter from SEC
12:00am
8-K
m6pbbqliuwhyxgn1
13 Aug 20
Histogen Reports Second Quarter 2020 Earnings and Provides Business Update
4:10pm
8-K
zc6u6k7k 7u8f7l
10 Aug 20
Regulation FD Disclosure
12:00am